181 related articles for article (PubMed ID: 21269261)
1. Repressing the activity of protein kinase CK2 releases the brakes on mitochondria-mediated apoptosis in cancer cells.
Hanif IM; Pervaiz S
Curr Drug Targets; 2011 Jun; 12(6):902-8. PubMed ID: 21269261
[TBL] [Abstract][Full Text] [Related]
2. Casein Kinase II: an attractive target for anti-cancer drug design.
Hanif IM; Hanif IM; Shazib MA; Ahmad KA; Pervaiz S
Int J Biochem Cell Biol; 2010 Oct; 42(10):1602-5. PubMed ID: 20558317
[TBL] [Abstract][Full Text] [Related]
3. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
Izeradjene K; Douglas L; Delaney A; Houghton JA
Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
[TBL] [Abstract][Full Text] [Related]
4. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
Ravi R; Bedi A
Cancer Res; 2002 Aug; 62(15):4180-5. PubMed ID: 12154014
[TBL] [Abstract][Full Text] [Related]
5. Role of protein kinase CK2 in the regulation of tumor necrosis factor-related apoptosis inducing ligand-induced apoptosis in prostate cancer cells.
Wang G; Ahmad KA; Ahmed K
Cancer Res; 2006 Feb; 66(4):2242-9. PubMed ID: 16489027
[TBL] [Abstract][Full Text] [Related]
6. Casein kinase II (CK2) enhances death-inducing signaling complex (DISC) activity in TRAIL-induced apoptosis in human colon carcinoma cell lines.
Izeradjene K; Douglas L; Delaney A; Houghton JA
Oncogene; 2005 Mar; 24(12):2050-8. PubMed ID: 15688023
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase CK2 inhibition induces cell death via early impact on mitochondrial function.
Qaiser F; Trembley JH; Kren BT; Wu JJ; Naveed AK; Ahmed K
J Cell Biochem; 2014 Dec; 115(12):2103-15. PubMed ID: 25043911
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of apoptosis repressor with caspase recruitment domain by protein kinase CK2 contributes to chemotherapy resistance by inhibiting doxorubicin induced apoptosis.
Wang J; Feng C; He Y; Ding W; Sheng J; Arshad M; Zhang X; Li P
Oncotarget; 2015 Sep; 6(29):27700-13. PubMed ID: 26172393
[TBL] [Abstract][Full Text] [Related]
9. Emergence of protein kinase CK2 as a key target in cancer therapy.
Trembley JH; Chen Z; Unger G; Slaton J; Kren BT; Van Waes C; Ahmed K
Biofactors; 2010; 36(3):187-95. PubMed ID: 20533398
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid hormone-related protein (PTHrP) inhibits mitochondrial-dependent apoptosis through CK2.
Okoumassoun LE; Russo C; Denizeau F; Averill-Bates D; Henderson JE
J Cell Physiol; 2007 Sep; 212(3):591-9. PubMed ID: 17443683
[TBL] [Abstract][Full Text] [Related]
11. [Casein kinase 2, the versatile regulator of cell survival].
Volodina IuL; Shtil' AA
Mol Biol (Mosk); 2012; 46(3):423-33. PubMed ID: 22888632
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase CK2 subunits are positive regulators of AKT kinase.
Guerra B
Int J Oncol; 2006 Mar; 28(3):685-93. PubMed ID: 16465374
[TBL] [Abstract][Full Text] [Related]
13. [Effects of mitoxantrone on the activity of human protein kinase CK2 holoenzyme].
Li CM; Liu XG; Lin XC; Chen XW; Liang NC
Ai Zheng; 2008 Aug; 27(8):809-15. PubMed ID: 18710613
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of catalase and oxidative modification of protein kinase CK2 lead to the failure of apoptosis repressor with caspase recruitment domain to inhibit cardiomyocyte hypertrophy.
Murtaza I; Wang HX; Feng X; Alenina N; Bader M; Prabhakar BS; Li PF
J Biol Chem; 2008 Mar; 283(10):5996-6004. PubMed ID: 18171680
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase CK2 inhibition as a pharmacological strategy.
Borgo C; Ruzzene M
Adv Protein Chem Struct Biol; 2021; 124():23-46. PubMed ID: 33632467
[TBL] [Abstract][Full Text] [Related]
16. Chemically induced degradation of CK2 by proteolysis targeting chimeras based on a ubiquitin-proteasome pathway.
Chen H; Chen F; Liu N; Wang X; Gou S
Bioorg Chem; 2018 Dec; 81():536-544. PubMed ID: 30245235
[TBL] [Abstract][Full Text] [Related]
17. Too much of a good thing: the role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2.
Duncan JS; Litchfield DW
Biochim Biophys Acta; 2008 Jan; 1784(1):33-47. PubMed ID: 17931986
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase CK2 in health and disease: CK2: a key player in cancer biology.
Trembley JH; Wang G; Unger G; Slaton J; Ahmed K
Cell Mol Life Sci; 2009 Jun; 66(11-12):1858-67. PubMed ID: 19387548
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological inhibition of protein kinase CK2 reverts the multidrug resistance phenotype of a CEM cell line characterized by high CK2 level.
Di Maira G; Brustolon F; Bertacchini J; Tosoni K; Marmiroli S; Pinna LA; Ruzzene M
Oncogene; 2007 Oct; 26(48):6915-26. PubMed ID: 17486073
[TBL] [Abstract][Full Text] [Related]
20. Involvement of reactive oxygen species in apoptosis induced by pharmacological inhibition of protein kinase CK2.
Hanif IM; Ahmad KA; Ahmed K; Pervaiz S
Ann N Y Acad Sci; 2009 Aug; 1171():591-9. PubMed ID: 19723109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
